BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Romanque P, Piguet AC, Dufour JF. Targeting vessels to treat hepatocellular carcinoma. Clin Sci (Lond). 2008;114:467-477. [PMID: 18302534 DOI: 10.1042/CS20070310] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 Lin E, Liu X, Liu Y, Zhang Z, Xie L, Tian K, Liu J, Yu Y. Roles of the Dynamic Tumor Immune Microenvironment in the Individualized Treatment of Advanced Clear Cell Renal Cell Carcinoma. Front Immunol 2021;12:653358. [PMID: 33746989 DOI: 10.3389/fimmu.2021.653358] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Yao DF, Gu WJ, Li YM. Expression and dynamic alteration of hepatoma-related growth factors during malignant transformation of hepatocytes. Shijie Huaren Xiaohua Zazhi 2008; 16(23): 2570-2575 [DOI: 10.11569/wcjd.v16.i23.2570] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Ku CY, Liu YH, Lin HY, Lu SC, Lin JY. Liver fatty acid-binding protein (L-FABP) promotes cellular angiogenesis and migration in hepatocellular carcinoma. Oncotarget 2016;7:18229-46. [PMID: 26919097 DOI: 10.18632/oncotarget.7571] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
4 Wysmołek ME, Długosz E, Wiśniewski M. The Immunological Role of Vascular and Lymphatic Endothelial Cells in Filarial Infections. Animals 2022;12:426. [DOI: 10.3390/ani12040426] [Reference Citation Analysis]